Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · September 29, 2023

Changes in Healthcare Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Patients With Melanoma

JAMA Dermatology

 

Additional Info

JAMA Dermatology
Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma
JAMA Dermatol 2023 Sep 06;[EPub Ahead of Print], SB Bateni, P Nguyen, A Eskander, SJ Seung, N Mittmann, M Jalink, A Gupta, KKW Chan, NJ Look Hong, TP Hanna

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading